Abstract Body

Background: CCR5 is a G protein-coupled receptor (GPCR). GPCR dimerization may result in a change in cell surface density, in ligand specificity and affinity and in the nature and intensity of the signaling pathway. Therefore, we looked for GPCR able to dimerize with CCR5 at the CD4 T cell surface. Methodology: We identified by multi quantitaiive RT-PCR the GPCR coexpressed with CCR5 in circulating CD4 T cells. GPCR dimerization was evidenced by time-resolved FRET. Using HIV gene transfer vectors, we established two cell lines expressing or not the sphingosine-1-phosphate receptor 1 (S1P1). HIV infectibility by replicative and non-replicative HIV-1 strains was measured in both cell lines. The effect of S1P1 expression on LTR activation was studied in cells stably transfected with a reporter gene driven by HIV LTR and transduced with the S1P1 gene. S1P1 expression at the surface of primary cells was measured by flow cytometry. The effect of the S1P1 antagonist FTY720 was tested on SCID mice reconstituted with human peripheral blood mononuclear cells (PBMC) and infected with the HIV-1 R5 strain JR-CSF. Results: We identified 250 GPCR coexpressed with CCR5 in circulating CD4 T cells. Among the GPCR the most expressed, we found that S1P1 dimerized with CCR5 at the cell surface. S1P1 coexpression resulted in a decrease in HIV-1 R5 virion entry, but not in cell to cell propagation. By contrast, S1P1 coexpression boosted LTR activation. Altogether these effects resulted in the increase in replicative HIV-1 R5 infection. We detected S1P1 at the surface of monocyte-derived dendritic cells, and FTY720 inhibited R5 infection in these cells. Moreover, this S1P1 antagonist inhibited HIV-1 R5 infection in a mouse model. Conclusions: S1P1 dimerizes with CCR5 and its expression increases HIV-1 R5 replication. Consequently, an S1P1 antagonist inhibited R5 infection in vitro and in vivo. S1P1 might also impair the chemokine receptor function of CCR5, and vice versa.